By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit
www.amgen.com and follow us on www.twitter.com/amgen.

FOLLOW AMGEN:





Key Statistics


Email:
Ownership: Public

Web Site: Amgen
Employees: 7,300+ Worldwide
Symbol: AMGN
 





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax  Antibody phage display





Company News
Amgen (AMGN) Remains Hush-Hush Over FDA Rejection of Parsabiv 8/25/2016 5:44:32 AM
Amgen (AMGN) Release: New Data Add To Understanding Of Repatha (Evolocumab) In Multiple Patient Populations 8/22/2016 7:58:28 AM
A Look at Amgen (AMGN)'s Pipeline: Will it Help the Company Grow? 8/19/2016 6:29:19 AM
Amgen (AMGN) Launches Commerical Office In Hong Kong 8/11/2016 6:34:34 AM
After a Dazzling Second Quarter, Amgen (AMGN) Develops Strategy to Deal With Upcoming Biosimilar Competition 8/11/2016 6:33:49 AM
AbbVie (ABBV) Sues Amgen (AMGN) To Fend Off Copy Of $4 Billion Humira Drug 8/5/2016 10:24:54 AM
Amgen (AMGN) Forges Pre-clinical R&D Pact Worth $540 Million With Advaxis (ADXS) 8/2/2016 6:29:49 AM
A Look at Four Biotech Giants' Q2 Earnings 7/29/2016 6:54:11 AM
Amgen (AMGN) Reports Second Quarter 2016 Financial Results 7/28/2016 7:38:56 AM
Amgen (AMGN) Restructuring Plan That Laid Off Hundreds Is Paying Off, CEO Says 7/28/2016 6:47:18 AM
12345678910...
//-->